ARCHIVES

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 7 | July 30, 2010

Download PDF Visit The Full Archive

Related Articles

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

ORI Finds Misconduct By Two Researchers

December 8, 1995

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012